These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19430886)
1. Investigation of immunosuppressive mechanisms in a mouse glioma model. Ksendzovsky A; Feinstein D; Zengou R; Sharp A; Polak P; Lichtor T; Glick RP J Neurooncol; 2009 May; 93(1):107-14. PubMed ID: 19430886 [TBL] [Abstract][Full Text] [Related]
2. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo. Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237 [TBL] [Abstract][Full Text] [Related]
3. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115 [TBL] [Abstract][Full Text] [Related]
4. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cantini G; Pisati F; Mastropietro A; Frattini V; Iwakura Y; Finocchiaro G; Pellegatta S Cancer Immunol Immunother; 2011 Dec; 60(12):1739-50. PubMed ID: 21779877 [TBL] [Abstract][Full Text] [Related]
5. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221 [TBL] [Abstract][Full Text] [Related]
6. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg. Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu. Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711 [TBL] [Abstract][Full Text] [Related]
8. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8. Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269 [TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1. Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578 [TBL] [Abstract][Full Text] [Related]
10. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. Panek WK; Pituch KC; Miska J; Kim JW; Rashidi A; Kanojia D; Lopez-Rosas A; Han Y; Yu D; Chang CL; Kane JR; Zhang P; Cordero A; Lesniak MS Mol Neurobiol; 2019 Jul; 56(7):5032-5040. PubMed ID: 30460615 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo. Sumitomo S; Fujio K; Okamura T; Morita K; Ishigaki K; Suzukawa K; Kanaya K; Kondo K; Yamasoba T; Furukawa A; Kitahara N; Shoda H; Shibuya M; Okamoto A; Yamamoto K J Immunol; 2013 Sep; 191(5):2351-9. PubMed ID: 23904169 [TBL] [Abstract][Full Text] [Related]
12. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Wu A; Wei J; Kong LY; Wang Y; Priebe W; Qiao W; Sawaya R; Heimberger AB Neuro Oncol; 2010 Nov; 12(11):1113-25. PubMed ID: 20667896 [TBL] [Abstract][Full Text] [Related]
13. Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer. Liu XS; Lin XK; Mei Y; Ahmad S; Yan CX; Jin HL; Yu H; Chen C; Lin CZ; Yu JR Front Immunol; 2019; 10():1741. PubMed ID: 31417548 [No Abstract] [Full Text] [Related]
14. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression. Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168 [TBL] [Abstract][Full Text] [Related]
15. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8. Edwards JP; Thornton AM; Shevach EM J Immunol; 2014 Sep; 193(6):2843-9. PubMed ID: 25127859 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells. Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387 [TBL] [Abstract][Full Text] [Related]
17. The role of regulatory T-cells in glioma immunology. Ooi YC; Tran P; Ung N; Thill K; Trang A; Fong BM; Nagasawa DT; Lim M; Yang I Clin Neurol Neurosurg; 2014 Apr; 119():125-32. PubMed ID: 24582432 [TBL] [Abstract][Full Text] [Related]
18. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Ueda R; Fujita M; Zhu X; Sasaki K; Kastenhuber ER; Kohanbash G; McDonald HA; Harper J; Lonning S; Okada H Clin Cancer Res; 2009 Nov; 15(21):6551-9. PubMed ID: 19861464 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422 [TBL] [Abstract][Full Text] [Related]
20. TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment. Wu M; Chen X; Lou J; Zhang S; Zhang X; Huang L; Sun R; Huang P; Wang F; Pan S Oncotarget; 2016 Jul; 7(28):44534-44544. PubMed ID: 27322208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]